aspirin has been researched along with Cirrhosis, Liver in 63 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Despite the overall association of aspirin on reduced hepatocellular carcinoma (HCC) risk, there have been few studies on its benefit according to specific clinical conditions among hepatitis B virus (HBV)-infected patients." | 8.12 | Clinical Indication of Aspirin Associated With Reduced Risk of Liver Cancer in Chronic Hepatitis B: A Nationwide Cohort Study. ( Ahn, SH; Kim, BK; Yoon, JH; Yun, B, 2022) |
| "This retrospective multicenter study provides first data indicating a beneficial effect of aspirin on transplant-free survival after TIPS implantation in patients with refractory ascites." | 8.12 | Aspirin improves transplant-free survival after TIPS implantation in patients with refractory ascites: a retrospective multicentre cohort study. ( Bettinger, D; Gu, W; Heinzow, H; Huber, JP; Jansen, C; Köhler, M; Maschmeier, M; Masthoff, M; Meyer, C; Praktiknjo, M; Schindler, P; Schmidt, HH; Schoster, M; Schultheiss, M; Seifert, LL; Seifert, QE; Sturm, L; Trebicka, J; Weller, JF; Wildgruber, M; Wilms, C, 2022) |
| "Aspirin therapy has been associated with reduced risk of colon cancer, but there is only limited evidence for its effects on risk of hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC)." | 7.96 | Association of Daily Aspirin Therapy With Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis C Virus Infection. ( Hsu, YC; Lee, TY; Lin, JT; Tseng, HC; Wu, CY; Wu, MS, 2020) |
| "Aspirin use may have chemo-preventive effect on recurrence of hepatitis B virus-related HCC after curative resection." | 7.96 | Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection. ( Chao, Y; Chau, GY; Hou, MC; Huang, YH; Huo, TI; Lee, IC; Lee, MH; Lin, HC; Su, CW; Yeh, YC; Young, SH, 2020) |
| "The effect of aspirin on the risk of hepatocellular carcinoma (HCC) remains unclear." | 7.88 | Aspirin Use and Risk of Hepatocellular Carcinoma in a National Cohort Study of Korean Adults. ( Chang, J; Hwang, IC; Kim, K; Park, SM, 2018) |
| "For aspirin, the RR was 1." | 5.91 | Effects of statins and aspirin on HCC risk in alcohol-related cirrhosis: nationwide emulated trials. ( Christensen, DH; Eiset, AH; Jepsen, P; Kraglund, F; Villadsen, GE; West, J, 2023) |
| "Aspirin use was associated with reduced risks of HCC and liver-associated mortality in adults with CHB." | 5.72 | Aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B with or without cirrhosis. ( Cho, EJ; Chung, JW; Jang, H; Kim, YJ; Lee, J; Lee, JH; Lee, YB; Moon, H; Nam, JY; Yoon, JH; Yu, SJ, 2022) |
| "Despite the overall association of aspirin on reduced hepatocellular carcinoma (HCC) risk, there have been few studies on its benefit according to specific clinical conditions among hepatitis B virus (HBV)-infected patients." | 4.12 | Clinical Indication of Aspirin Associated With Reduced Risk of Liver Cancer in Chronic Hepatitis B: A Nationwide Cohort Study. ( Ahn, SH; Kim, BK; Yoon, JH; Yun, B, 2022) |
| "This retrospective multicenter study provides first data indicating a beneficial effect of aspirin on transplant-free survival after TIPS implantation in patients with refractory ascites." | 4.12 | Aspirin improves transplant-free survival after TIPS implantation in patients with refractory ascites: a retrospective multicentre cohort study. ( Bettinger, D; Gu, W; Heinzow, H; Huber, JP; Jansen, C; Köhler, M; Maschmeier, M; Masthoff, M; Meyer, C; Praktiknjo, M; Schindler, P; Schmidt, HH; Schoster, M; Schultheiss, M; Seifert, LL; Seifert, QE; Sturm, L; Trebicka, J; Weller, JF; Wildgruber, M; Wilms, C, 2022) |
| "Aspirin therapy has been associated with reduced risk of colon cancer, but there is only limited evidence for its effects on risk of hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC)." | 3.96 | Association of Daily Aspirin Therapy With Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis C Virus Infection. ( Hsu, YC; Lee, TY; Lin, JT; Tseng, HC; Wu, CY; Wu, MS, 2020) |
| "Aspirin use may have chemo-preventive effect on recurrence of hepatitis B virus-related HCC after curative resection." | 3.96 | Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection. ( Chao, Y; Chau, GY; Hou, MC; Huang, YH; Huo, TI; Lee, IC; Lee, MH; Lin, HC; Su, CW; Yeh, YC; Young, SH, 2020) |
| "The effect of aspirin on the risk of hepatocellular carcinoma (HCC) remains unclear." | 3.88 | Aspirin Use and Risk of Hepatocellular Carcinoma in a National Cohort Study of Korean Adults. ( Chang, J; Hwang, IC; Kim, K; Park, SM, 2018) |
| "96) as well as history of hematemesis, melena in the past 30 days, positive nasogastric aspirate, prior upper gastrointestinal bleeding or use of aspirin or non-steroidal anti-inflammatory." | 3.83 | Origin, Clinical Characteristics and 30-Day Outcomes of Severe Hematochezia in Cirrhotics and Non-cirrhotics. ( Camus, M; Dulai, GS; Ghassemi, KA; Jensen, DM; Jutabha, R; Khungar, V; Kovacs, TO; Machicado, GA; Ohning, GV, 2016) |
| " The dog had a history of hypothyroidism, which was controlled with levothyroxine." | 3.72 | Portal vein and aortic thromboses in a Siberian husky with ehrlichiosis and hypothyroidism. ( Bressler, C; Himes, LC; Moreau, RE, 2003) |
| "Warfarin treatment was associated with better liver function protection and renal function improvement than aspirin treatment." | 2.90 | Warfarin versus aspirin prevents portal vein thrombosis after laparoscopic splenectomy and azygoportal disconnection: A randomized clinical trial. ( Bai, DS; Jiang, GQ; Jin, SJ; Qian, JJ; Xia, BL; Ye, J; Zhang, C, 2019) |
| "Aspirin may cause a transient shedding of renal tubular cells, alterations in urate excretion, inhibition of spironolactone action, and, in certain clinical settings, a reversible decline in renal function manifested as a fall in glomerular filtration that may be accompanied by mild water, sodium, and potassium retention." | 2.36 | Acute effects of aspirin and acetaminophen on renal function. ( Kimberly, RP; Plotz, PH, 1981) |
| "For aspirin, the RR was 1." | 1.91 | Effects of statins and aspirin on HCC risk in alcohol-related cirrhosis: nationwide emulated trials. ( Christensen, DH; Eiset, AH; Jepsen, P; Kraglund, F; Villadsen, GE; West, J, 2023) |
| "Aspirin use was associated with reduced risks of HCC and liver-associated mortality in adults with CHB." | 1.72 | Aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B with or without cirrhosis. ( Cho, EJ; Chung, JW; Jang, H; Kim, YJ; Lee, J; Lee, JH; Lee, YB; Moon, H; Nam, JY; Yoon, JH; Yu, SJ, 2022) |
| "Aspirin (30 mg/kg) was administered to rats by gavage once every morning over a period of 8 weeks." | 1.72 | Aspirin attenuates liver fibrosis by suppressing TGF‑β1/Smad signaling. ( Hu, X; Jiang, X; Liu, B; Sun, Y; Xiang, J; Xiao, B; Xie, J, 2022) |
| "Animals without steatosis (ie NAFLD) at week 16 were excluded from the data analysis." | 1.62 | The effect of acetylsalicylic acid and pentoxifylline in guinea pigs with non-alcoholic steatohepatitis. ( Andersen, M; Buelund, LE; Ipsen, DH; Latta, M; Lintrup, K; Lykkesfeldt, J; Skaarup, R; Skat-Rørdam, J; Svenningsen, M; Tveden-Nyborg, P, 2021) |
| "Aspirin is a non-steroidal anti-inflammatory drug used to relieve both inflammatory symptoms and pain." | 1.56 | Aspirin alleviates hepatic fibrosis by suppressing hepatic stellate cells activation via the TLR4/NF-κB pathway. ( Duan, L; Jia, Y; Liu, Y; Lu, Y; Nong, L; Tan, A; Zhao, J, 2020) |
| "The degree of liver fibrosis was determined using four validated fibrosis indices and a composite index." | 1.43 | Aspirin use is associated with lower indices of liver fibrosis among adults in the United States. ( Afdhal, N; Feldbrügge, L; Ghaziani, T; Jiang, ZG; Mukamal, KJ; Popov, Y; Robson, SC; Tapper, EB, 2016) |
| "Liver fibrosis was assessed by histological evaluation." | 1.40 | Aspirin may reduce liver fibrosis progression: Evidence from a multicenter retrospective study of recurrent hepatitis C after liver transplantation. ( Boëlle, PY; Chazouillères, O; Conti, F; Corpechot, C; Durand, F; Duvoux, C; Mackiewicz, V; Paradis, V; Poujol-Robert, A; Poupon, R; Wendum, D, 2014) |
| "MOR8457 also reduced liver fibrosis in mice placed on DDC-supplemented diets." | 1.40 | Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice. ( Arch, RH; Chung, J; Ikenaga, N; Kim, YO; Liu, SB; Miyamoto, M; Ogawa, S; Peng, ZW; Popov, Y; Schuppan, D; Sverdlov, DY; Yoshida, S, 2014) |
| "The gastric toxic effects of aspirin (ASA) and NCX-4016, a nitric oxide (NO)-releasing ASA, were compared in normal, cirrhotic, and arthritic rats." | 1.31 | Low gastric toxicity of nitric oxide-releasing aspirin, NCX-4016, in rats with cirrhosis and arthritis. ( Kato, S; Komoike, Y; Suzuki, K; Takeuchi, K; Ukawa, H, 2001) |
| "Acute bleeding from oesophageal varices is a major complication of cirrhosis of the liver." | 1.30 | Anti-inflammatory drugs and variceal bleeding: a case-control study. ( Beauchant, M; Becker, MC; Bernard, P; De Lédinghen, V; Fourdan, O; Gourlaouen, A; Heresbach, D; Ingrand, P; Liebaert-Bories, MP; Nousbaum, JB; Ribard, D; Silvain, C, 1999) |
| "In 8 patients with liver cirrhosis who underwent hepatectomy, one patient with a prolonged T2 (260 secs) and a normal skin BT bled postoperatively, however, 3 patients with a prolonged skin BT (greater than 15 min) and a normal T2 had no hemorrhagic complications." | 1.27 | Clinical application of a new in vitro bleeding time device on surgical patients. ( Itoh, T; Kambayashi, J; Mori, T; Sakon, M; Tsujinaka, T; Uemura, Y, 1988) |
| "The charts of 238 patients with systemic lupus erythematosus (SLE) were reviewed." | 1.26 | The spectrum of liver disease in systemic lupus erythematosus. Report of 33 histologically-proved cases and review of the literature. ( Anuras, S; LaBrecque, DR; Runyon, BA, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (41.27) | 18.7374 |
| 1990's | 2 (3.17) | 18.2507 |
| 2000's | 4 (6.35) | 29.6817 |
| 2010's | 18 (28.57) | 24.3611 |
| 2020's | 13 (20.63) | 2.80 |
| Authors | Studies |
|---|---|
| Jang, H | 1 |
| Lee, YB | 1 |
| Moon, H | 1 |
| Chung, JW | 1 |
| Nam, JY | 1 |
| Cho, EJ | 1 |
| Lee, JH | 2 |
| Yu, SJ | 1 |
| Kim, YJ | 1 |
| Lee, J | 1 |
| Yoon, JH | 2 |
| Guidotti, LG | 1 |
| La Vecchia, C | 1 |
| Colombo, M | 1 |
| Yun, B | 1 |
| Ahn, SH | 1 |
| Kim, BK | 1 |
| Sun, Y | 1 |
| Liu, B | 1 |
| Xie, J | 1 |
| Jiang, X | 1 |
| Xiao, B | 1 |
| Hu, X | 1 |
| Xiang, J | 1 |
| Seifert, LL | 1 |
| Schindler, P | 1 |
| Sturm, L | 1 |
| Gu, W | 1 |
| Seifert, QE | 1 |
| Weller, JF | 1 |
| Jansen, C | 1 |
| Praktiknjo, M | 1 |
| Meyer, C | 1 |
| Schoster, M | 1 |
| Wilms, C | 1 |
| Maschmeier, M | 1 |
| Schmidt, HH | 1 |
| Masthoff, M | 1 |
| Köhler, M | 1 |
| Schultheiss, M | 1 |
| Huber, JP | 1 |
| Bettinger, D | 1 |
| Trebicka, J | 1 |
| Wildgruber, M | 1 |
| Heinzow, H | 1 |
| Li, Y | 2 |
| Fu, X | 1 |
| Liu, P | 1 |
| Liu, S | 1 |
| Pan, Y | 1 |
| Kraglund, F | 1 |
| Christensen, DH | 1 |
| Eiset, AH | 1 |
| Villadsen, GE | 1 |
| West, J | 1 |
| Jepsen, P | 1 |
| Du, ZQ | 1 |
| Zhao, JZ | 1 |
| Dong, J | 1 |
| Bi, JB | 1 |
| Ren, YF | 1 |
| Zhang, J | 1 |
| Khalid, B | 1 |
| Wu, Z | 1 |
| Lv, Y | 1 |
| Zhang, XF | 1 |
| Wu, RQ | 1 |
| Severo, MD | 1 |
| Liu, Y | 2 |
| Nong, L | 1 |
| Jia, Y | 1 |
| Tan, A | 1 |
| Duan, L | 1 |
| Lu, Y | 1 |
| Zhao, J | 1 |
| Lee, TY | 1 |
| Hsu, YC | 1 |
| Tseng, HC | 1 |
| Lin, JT | 1 |
| Wu, MS | 1 |
| Wu, CY | 1 |
| Ipsen, DH | 1 |
| Skat-Rørdam, J | 1 |
| Svenningsen, M | 1 |
| Andersen, M | 1 |
| Latta, M | 1 |
| Buelund, LE | 1 |
| Lintrup, K | 1 |
| Skaarup, R | 1 |
| Lykkesfeldt, J | 1 |
| Tveden-Nyborg, P | 1 |
| Ren, T | 1 |
| Xu, X | 1 |
| Jin, J | 1 |
| Ponzetto, A | 1 |
| Figura, N | 1 |
| Feagins, LA | 1 |
| Wan, YM | 1 |
| Li, YH | 1 |
| Wu, HM | 1 |
| Xu, ZY | 1 |
| Xu, Y | 1 |
| Yang, LH | 1 |
| Wu, XN | 1 |
| Yang, JH | 1 |
| Hwang, IC | 1 |
| Chang, J | 1 |
| Kim, K | 1 |
| Park, SM | 1 |
| Patel, SS | 1 |
| Guzman, LA | 1 |
| Lin, FP | 1 |
| Pence, T | 1 |
| Reichman, T | 1 |
| John, B | 1 |
| Celi, FS | 1 |
| Liptrap, E | 1 |
| Bhati, C | 1 |
| Siddiqui, MS | 1 |
| VanWagner, LB | 1 |
| So, S | 1 |
| Ahn, JY | 1 |
| Kim, N | 1 |
| Na, HK | 1 |
| Jung, KW | 1 |
| Kim, DH | 1 |
| Choi, KD | 1 |
| Song, HJ | 1 |
| Lee, GH | 1 |
| Jung, HY | 1 |
| Bai, DS | 2 |
| Xia, BL | 2 |
| Zhang, C | 1 |
| Ye, J | 1 |
| Qian, JJ | 2 |
| Jin, SJ | 2 |
| Jiang, GQ | 2 |
| Simon, TG | 1 |
| Henson, J | 1 |
| Osganian, S | 1 |
| Masia, R | 1 |
| Chan, AT | 1 |
| Chung, RT | 1 |
| Corey, KE | 1 |
| Young, SH | 1 |
| Chau, GY | 1 |
| Lee, IC | 1 |
| Yeh, YC | 1 |
| Chao, Y | 1 |
| Huo, TI | 1 |
| Su, CW | 1 |
| Lin, HC | 1 |
| Hou, MC | 1 |
| Lee, MH | 1 |
| Huang, YH | 1 |
| Vilar-Gomez, E | 1 |
| Chalasani, N | 1 |
| Poujol-Robert, A | 1 |
| Boëlle, PY | 1 |
| Conti, F | 1 |
| Durand, F | 1 |
| Duvoux, C | 1 |
| Wendum, D | 1 |
| Paradis, V | 1 |
| Mackiewicz, V | 1 |
| Chazouillères, O | 1 |
| Corpechot, C | 1 |
| Poupon, R | 1 |
| Yoshida, S | 1 |
| Ikenaga, N | 1 |
| Liu, SB | 1 |
| Peng, ZW | 1 |
| Chung, J | 1 |
| Sverdlov, DY | 1 |
| Miyamoto, M | 1 |
| Kim, YO | 1 |
| Ogawa, S | 1 |
| Arch, RH | 1 |
| Schuppan, D | 1 |
| Popov, Y | 2 |
| Jiang, ZG | 1 |
| Feldbrügge, L | 1 |
| Tapper, EB | 1 |
| Ghaziani, T | 1 |
| Afdhal, N | 1 |
| Robson, SC | 1 |
| Mukamal, KJ | 1 |
| Chen, P | 1 |
| Zuo, SQ | 1 |
| Camus, M | 1 |
| Khungar, V | 1 |
| Jensen, DM | 1 |
| Ohning, GV | 1 |
| Kovacs, TO | 1 |
| Jutabha, R | 1 |
| Ghassemi, KA | 1 |
| Machicado, GA | 1 |
| Dulai, GS | 1 |
| Scharf, RE | 1 |
| Pivalizza, EG | 1 |
| Melnikov, V | 1 |
| Guzman-Reyes, S | 1 |
| Marasigan, B | 1 |
| Russo, MW | 1 |
| Pierson, J | 1 |
| Narang, T | 1 |
| Montegudo, A | 1 |
| Eskind, L | 1 |
| Gulati, S | 1 |
| MENGUY, R | 3 |
| Bressler, C | 1 |
| Himes, LC | 1 |
| Moreau, RE | 1 |
| Füessl, HS | 1 |
| Planas, R | 2 |
| Arroyo, V | 3 |
| Rimola, A | 3 |
| Pérez-Ayuso, RM | 3 |
| Rodés, J | 3 |
| Gaya, J | 2 |
| Deulofeu, R | 1 |
| Rivera, F | 2 |
| Camps, J | 1 |
| Costa, J | 1 |
| Dunn, MJ | 1 |
| Plotz, PH | 1 |
| Kimberly, RP | 1 |
| Runyon, BA | 1 |
| LaBrecque, DR | 1 |
| Anuras, S | 1 |
| D'Abrigeon, G | 1 |
| Blanc, P | 1 |
| Durand, L | 1 |
| Larrey, D | 1 |
| Michel, H | 1 |
| De Lédinghen, V | 1 |
| Heresbach, D | 1 |
| Fourdan, O | 1 |
| Bernard, P | 1 |
| Liebaert-Bories, MP | 1 |
| Nousbaum, JB | 1 |
| Gourlaouen, A | 1 |
| Becker, MC | 1 |
| Ribard, D | 1 |
| Ingrand, P | 1 |
| Silvain, C | 1 |
| Beauchant, M | 1 |
| Kato, S | 1 |
| Suzuki, K | 1 |
| Ukawa, H | 1 |
| Komoike, Y | 1 |
| Takeuchi, K | 2 |
| Damus, PS | 1 |
| Wallace, GA | 1 |
| Franco, D | 1 |
| Durandy, Y | 1 |
| Deporte, A | 1 |
| Bismuth, H | 1 |
| Couinaud, C | 1 |
| Schirru, PL | 1 |
| Okabe, S | 2 |
| Urushidani, T | 1 |
| Naganuma, T | 1 |
| Takagi, K | 1 |
| Tsujinaka, T | 1 |
| Itoh, T | 1 |
| Uemura, Y | 1 |
| Sakon, M | 1 |
| Kambayashi, J | 1 |
| Mori, T | 1 |
| Laffi, G | 1 |
| La Villa, G | 1 |
| Pinzani, M | 1 |
| Ciabattoni, G | 1 |
| Patrignani, P | 1 |
| Mannelli, M | 1 |
| Cominelli, F | 1 |
| Gentilini, P | 1 |
| Bernardi, P | 1 |
| Ghezzi, F | 1 |
| Bastagli, L | 1 |
| Grimaldi, R | 1 |
| Cavazza, M | 1 |
| Minelli, C | 1 |
| Fontana, F | 1 |
| Clo', C | 1 |
| Ventura, C | 1 |
| Capelli, M | 1 |
| Mannucci, PM | 1 |
| Vicente, V | 1 |
| Vianello, L | 1 |
| Cattaneo, M | 1 |
| Alberca, I | 1 |
| Coccato, MP | 1 |
| Faioni, E | 1 |
| Mari, D | 1 |
| Sahud, MA | 1 |
| Desbaillets, L | 1 |
| Masters, YF | 1 |
| Minssart, F | 1 |
| Lataste, J | 1 |
| Le Picard, P | 1 |
| Steinberg, AD | 1 |
| Winckelmann, G | 1 |
| Benhamou, JP | 1 |
| Debray, C | 1 |
| Hamburger, J | 1 |
| Loygue, J | 1 |
| Roux, M | 1 |
| Pequignot, H | 1 |
| Okumura, H | 1 |
| Isoda, K | 1 |
| Aramaki, T | 1 |
| Ichikawa, T | 1 |
| Fukuda, N | 1 |
| Russell, AS | 1 |
| Sturge, RA | 1 |
| Smith, MA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Sclerotherapy With Polidocanol Foam in the Treatment of First, Second and Third-Grade Hemorrhoidal Disease in Patients With Liver Cirrhosis: A Prospective, Cohort Trial[NCT05807425] | Phase 2/Phase 3 | 40 participants (Anticipated) | Interventional | 2023-03-31 | Recruiting | ||
| Video Capsule Endoscopy for Lesion Localization and Diagnosis in Patients With Severe Hematochezia[NCT03616041] | 50 participants (Anticipated) | Observational | 2021-02-10 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for aspirin and Cirrhosis, Liver
| Article | Year |
|---|---|
Association of aspirin and nonaspirin NSAIDs therapy with the incidence risk of hepatocellular carcinoma: a systematic review and meta-analysis on cohort studies.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinoma, Hepatocellular; Cohort Studies; Hepatit | 2022 |
[Acquired platelet function disorders: pathogenesis, classification, frequency, diagnosis, clinical management].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelet Disorders; Blood Platelets; Coronar | 2008 |
CURRENT CONCEPTS OF THE ETIOLOGY OF DUODENAL ULCER.
Topics: Adrenal Cortex Hormones; Aspirin; Caffeine; Duodenal Ulcer; Gastric Juice; Gastric Mucosa; Genetics, | 1964 |
Acute effects of aspirin and acetaminophen on renal function.
Topics: Acetaminophen; Aspirin; Humans; Indomethacin; Kidney; Kidney Failure, Chronic; Liver Cirrhosis; Lupu | 1981 |
Platelet disorders: a review of disturbances in adhesion, aggregation, and release reaction.
Topics: Adenosine Diphosphate; Afibrinogenemia; Anemia; Aspirin; Blood Platelet Disorders; Connective Tissue | 1972 |
An approach to the use of immunosuppressive drugs in nonmalignant diseases.
Topics: Animals; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Aspirin; Chlorambucil; Cyclophosphamide; G | 1973 |
[Blood platelet diseases].
Topics: Adenosine Diphosphate; Afibrinogenemia; Aspirin; Blood Platelet Disorders; Blood Platelets; Diagnosi | 1973 |
3 trials available for aspirin and Cirrhosis, Liver
| Article | Year |
|---|---|
Warfarin versus aspirin prevents portal vein thrombosis after laparoscopic splenectomy and azygoportal disconnection: A randomized clinical trial.
Topics: Aged; Aged, 80 and over; Aspirin; Female; Humans; Incidence; Laparoscopy; Liver Cirrhosis; Male; Mid | 2019 |
Anticoagulation Therapy with Warfarin Versus Low-Dose Aspirin Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection.
Topics: Adolescent; Adult; Aged; Anticoagulants; Aspirin; Azygos Vein; Female; Heparin, Low-Molecular-Weight | 2016 |
Controlled trial of desmopressin in liver cirrhosis and other conditions associated with a prolonged bleeding time.
Topics: Adolescent; Adult; Aged; Aspirin; Bleeding Time; Clinical Trials as Topic; Deamino Arginine Vasopres | 1986 |
53 other studies available for aspirin and Cirrhosis, Liver
| Article | Year |
|---|---|
Aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B with or without cirrhosis.
Topics: Adult; Antiviral Agents; Aspirin; Carcinoma, Hepatocellular; Hepatitis B, Chronic; Humans; Incidence | 2022 |
Low-dose aspirin reduces the risk of HBV-associated HCC even when administered short-term: Too good to be true?
Topics: Aspirin; Carcinoma, Hepatocellular; Hepatitis B virus; Humans; Liver Cirrhosis; Liver Neoplasms; Ris | 2022 |
Clinical Indication of Aspirin Associated With Reduced Risk of Liver Cancer in Chronic Hepatitis B: A Nationwide Cohort Study.
Topics: Aspirin; Carcinoma, Hepatocellular; Cohort Studies; Female; Hepatitis B virus; Hepatitis B, Chronic; | 2022 |
Aspirin attenuates liver fibrosis by suppressing TGF‑β1/Smad signaling.
Topics: Animals; Aspirin; Hepatic Stellate Cells; Humans; Liver; Liver Cirrhosis; Rats; Rats, Sprague-Dawley | 2022 |
Aspirin improves transplant-free survival after TIPS implantation in patients with refractory ascites: a retrospective multicentre cohort study.
Topics: Ascites; Aspirin; Cohort Studies; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Human | 2022 |
Early prevention and risk factors analysis of portal vein system thrombosis after laparoscopic splenectomy and pericardial devascularization.
Topics: Anticoagulants; Aspirin; Humans; Hypertension, Portal; Laparoscopy; Liver Cirrhosis; Portal Vein; Ri | 2022 |
Effects of statins and aspirin on HCC risk in alcohol-related cirrhosis: nationwide emulated trials.
Topics: Aspirin; Carcinoma, Hepatocellular; Fibrosis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2023 |
Effect of low-dose aspirin administration on long-term survival of cirrhotic patients after splenectomy: A retrospective single-center study.
Topics: Adult; Aged; Aspirin; Carcinoma, Hepatocellular; Dose-Response Relationship, Drug; Female; Follow-Up | 2019 |
Daily Aspirin Use Associated With Reduced Risk for Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease.
Topics: Aspirin; Disease Progression; Fibrosis; Humans; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease | 2020 |
Aspirin alleviates hepatic fibrosis by suppressing hepatic stellate cells activation via the TLR4/NF-κB pathway.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Down-Regulation; Hepatic Stellate Cells; | 2020 |
Association of Daily Aspirin Therapy With Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis C Virus Infection.
Topics: Aged; Antiviral Agents; Aspirin; Carcinoma, Hepatocellular; Cohort Studies; Hepatitis C, Chronic; Hu | 2020 |
The effect of acetylsalicylic acid and pentoxifylline in guinea pigs with non-alcoholic steatohepatitis.
Topics: Animals; Aspirin; Diet, High-Fat; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Reposit | 2021 |
Letter: bleeding in cirrhotics receiving coronary stenting and antiplatelet therapy.
Topics: Aspirin; Drug Therapy, Combination; Hemorrhage; Humans; Liver Cirrhosis; Platelet Aggregation Inhibi | 2017 |
Letter: bleeding in cirrhotics receiving coronary stenting and antiplatelet therapy - author's reply.
Topics: Aspirin; Drug Therapy, Combination; Hemorrhage; Humans; Liver Cirrhosis; Platelet Aggregation Inhibi | 2017 |
Portal vein thrombosis before and after transjugular intrahepatic portosystemic shunt placement: An observational study (STROBE compliant).
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Clopidogrel; Female; Humans; Leukocyte Coun | 2017 |
Aspirin Use and Risk of Hepatocellular Carcinoma in a National Cohort Study of Korean Adults.
Topics: Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carcinogenesis; Carcinom | 2018 |
Utilization of aspirin and statin in management of coronary artery disease in patients with cirrhosis undergoing liver transplant evaluation.
Topics: Aged; Aspirin; Coronary Angiography; Coronary Artery Disease; Drug Therapy, Combination; Drug Utiliz | 2018 |
Asprin and statin use for management of atherosclerotic cardiovascular disease in liver transplant candidates: Are we missing the mark?
Topics: Aspirin; Coronary Artery Disease; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Cirr | 2018 |
Comparison of the effects of antithrombotic therapy on delayed bleeding after gastric endoscopic resection: a propensity score-matched case-control study.
Topics: Aged; Anticoagulants; Antithrombins; Aspirin; Case-Control Studies; Deprescriptions; Endoscopic Muco | 2019 |
Daily Aspirin Use Associated With Reduced Risk For Fibrosis Progression In Patients With Nonalcoholic Fatty Liver Disease.
Topics: Adult; Aged; Aspartate Aminotransferases; Aspirin; Cohort Studies; Disease Progression; Duration of | 2019 |
Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection.
Topics: Aged; alpha-Fetoproteins; Antiviral Agents; Aspirin; Carcinoma, Hepatocellular; Female; Hepatectomy; | 2020 |
Daily Aspirin Use Reduces Risk of Fibrosis Progression in Patients With Nonalcoholic Fatty Liver Disease, Providing New Uses for an Old Drug.
Topics: Aspirin; Disease Progression; Humans; Liver; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease | 2019 |
Aspirin may reduce liver fibrosis progression: Evidence from a multicenter retrospective study of recurrent hepatitis C after liver transplantation.
Topics: Aspirin; Disease Progression; Female; Hepatitis C, Chronic; Humans; Liver Cirrhosis; Liver Transplan | 2014 |
Extrahepatic platelet-derived growth factor-β, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antibodies, Monoclonal; Antibodies, Neutralizing; Aspirin; | 2014 |
Aspirin use is associated with lower indices of liver fibrosis among adults in the United States.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cross-Sectional Studies; Female; Hepatitis, | 2016 |
Origin, Clinical Characteristics and 30-Day Outcomes of Severe Hematochezia in Cirrhotics and Non-cirrhotics.
Topics: Aged; Aged, 80 and over; Angiodysplasia; Aspirin; Blood Component Transfusion; California; Case-Cont | 2016 |
Origin, Clinical Characteristics and 30-Day Outcomes of Severe Hematochezia in Cirrhotics and Non-cirrhotics.
Topics: Aged; Aged, 80 and over; Angiodysplasia; Aspirin; Blood Component Transfusion; California; Case-Cont | 2016 |
Origin, Clinical Characteristics and 30-Day Outcomes of Severe Hematochezia in Cirrhotics and Non-cirrhotics.
Topics: Aged; Aged, 80 and over; Angiodysplasia; Aspirin; Blood Component Transfusion; California; Case-Cont | 2016 |
Origin, Clinical Characteristics and 30-Day Outcomes of Severe Hematochezia in Cirrhotics and Non-cirrhotics.
Topics: Aged; Aged, 80 and over; Angiodysplasia; Aspirin; Blood Component Transfusion; California; Case-Cont | 2016 |
Thrombelastograph platelet mapping in a patient receiving antiplatelet therapy.
Topics: Aspirin; Blood Coagulation Disorders; Blood Platelets; Clopidogrel; Dose-Response Relationship, Drug | 2010 |
Coronary artery stents and antiplatelet therapy in patients with cirrhosis.
Topics: Aged; Aspirin; Clopidogrel; Coronary Artery Disease; Fatty Liver; Female; Follow-Up Studies; Gastroi | 2012 |
[ETIOLOGY OF THE DUODENAL ULCER].
Topics: Aspirin; Caffeine; Disease Susceptibility; Duodenal Ulcer; Genetics, Medical; Humans; Hyperparathyro | 1964 |
Portal vein and aortic thromboses in a Siberian husky with ehrlichiosis and hypothyroidism.
Topics: Animals; Aorta, Thoracic; Aspirin; Diagnosis, Differential; Dog Diseases; Dogs; Doxycycline; Ehrlich | 2003 |
[Family practice highlights of stomach, liver and intestinal reference points. Your arsenal against abdominal problems].
Topics: Alcohol Drinking; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Barrett Esophagus; Family Practi | 2007 |
Acetylsalicylic acid suppresses the renal hemodynamic effect and reduces the diuretic action of furosemide in cirrhosis with ascites.
Topics: Aspirin; Diuresis; Furosemide; Glomerular Filtration Rate; Humans; Kidney; Liver Cirrhosis; Liver Ci | 1983 |
Sympathetic nervous activity, renin-angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretion.
Topics: Ascites; Aspirin; Dinoprostone; Diuresis; Glomerular Filtration Rate; Humans; Kidney Diseases; Liver | 1983 |
Evidence that renal prostaglandins are involved in renal water metabolism in cirrhosis.
Topics: Arginine Vasopressin; Aspirin; Body Water; Depression, Chemical; Dinoprostone; Female; Glomerular Fi | 1984 |
Role of eicosanoids in the control of renal function in severe hepatic disease.
Topics: Animals; Arachidonic Acids; Aspirin; Dogs; Humans; Ibuprofen; Indomethacin; Kidney; Lipoxygenase; Li | 1984 |
The spectrum of liver disease in systemic lupus erythematosus. Report of 33 histologically-proved cases and review of the literature.
Topics: Adolescent; Adult; Aged; Aspirin; Biopsy; Chemical and Drug Induced Liver Injury; Child, Preschool; | 1980 |
[Liver cirrhosis and granulomatous hepatitis after prolonged ingestion of lysine acetylsalicylate].
Topics: Aged; Analgesics; Aspirin; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; | 1995 |
Anti-inflammatory drugs and variceal bleeding: a case-control study.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Esophageal and | 1999 |
Low gastric toxicity of nitric oxide-releasing aspirin, NCX-4016, in rats with cirrhosis and arthritis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Aspirin; Blood Flow Veloc | 2001 |
Immunologic measurement of antithrombin III-heparin cofactor and alpha2 macroglobulin in disseminated intravascular coagulation and hepatic failure coagulopathy.
Topics: Alpha-Globulins; Antithrombin III; Antithrombins; Aspirin; Blood Platelets; Chemical and Drug Induce | 1975 |
Upper gastrointestinal haemorrhage in hepatic cirrhosis: causes and relation to hepatic failure and stress.
Topics: Acute Disease; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aspirin; Chronic Disease; Esophagea | 1977 |
[The effect of splenectomy on the platelet disorder of cirrhotics (author's transl)].
Topics: Aspirin; Blood Platelet Disorders; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Mal | 1979 |
[Behaviour of "haemorrhage times" in hypocolinesterasic subjects after administration of acetil-salicylic acid (author's transl)].
Topics: Aspirin; Blood Coagulation; Cholinesterases; Hemorrhage; Hepatitis; Humans; Liver Cirrhosis; Preoper | 1977 |
Effects of L-glutamine on acetylsalicylic acid-induced gastric lesions in normal and cirrhotic rats.
Topics: Animals; Aspirin; Carbon Tetrachloride Poisoning; Gastrointestinal Hemorrhage; Glutamine; Intestinal | 1975 |
Clinical application of a new in vitro bleeding time device on surgical patients.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aspirin; Bleeding Time; Epoprostenol; Hemorrhage; Hemostasis; H | 1988 |
Altered renal and platelet arachidonic acid metabolism in cirrhosis.
Topics: 6-Ketoprostaglandin F1 alpha; Acute Kidney Injury; Adult; Aged; Arachidonic Acid; Arachidonic Acids; | 1986 |
Effects of polyunsaturated fatty acids and prostaglandin synthesis on renal function.
Topics: Aspirin; Body Water; Dinoprostone; Fatty Acids, Unsaturated; Heart Failure; Humans; Injections, Intr | 1986 |
Abnormal aspirin metabolism in patients with cirrhosis and its possible relationship to bleeding in cirrhotics.
Topics: Adult; Animals; Aspirin; Esterases; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Humans; Hyd | 1972 |
[Blood coagulation disorders of a toxic (alcoholism, drugs, poisoning) or iatrogenic (anticoagulants) nature].
Topics: Alcoholic Intoxication; Analgesics; Anticoagulants; Aspirin; Blood Coagulation Disorders; Blood Coag | 1972 |
[Upper digestive hemorrhages due to gastritis or of unknown cause. (Apropos of 140 cases)].
Topics: Alcoholism; Aspirin; Endoscopy; Esophageal and Gastric Varices; Fiber Optic Technology; Gastrectomy; | 1973 |
[Procedure to follow in case of severe hematemesis].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Aspirin; Blood Transfusion; Blood Volume Determin | 1969 |
[Aspirin esterase activity test as a new liver function test].
Topics: Animals; Aspirin; Clinical Enzyme Tests; Esterases; Heart Failure; Hepatitis; Humans; Hypoxia; Liver | 1971 |
Serum transaminases during salicylate therapy.
Topics: Adolescent; Adult; Age Factors; Aged; Alanine Transaminase; Alkaline Phosphatase; Arthritis, Juvenil | 1971 |